IVBXF - Lilly next-generation diabetes drug mazdutide meets primary goal in phase 3 trial
2024-05-09 12:40:14 ET
More on Eli Lilly
- Eli Lilly: Great Time To Divest Before It Potentially Crashes
- Eli Lilly Remains Expensive Here - Minimal Margin Of Safety
- Eli Lilly: Don't Overpay For Miracle Drugs
- Eli Lilly Alzheimer’s therapy set for June FDA AdCom meeting
- Pharma R&D productivity seen improving for the first time in years - Deloitte